Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OxyBand Technologies is a medical technology company that develops and commercializes advanced wound care products featuring integrated oxygen delivery. The company's core technology is the OxyBand Wound Dressing, the first FDA-cleared dressing that provides a continuous, localized supply of pure oxygen to a wound for up to five days. By maintaining high oxygen levels at the injury site, the dressing promotes faster healing, reduces infection risk, and manages pain for patients with chronic or acute wounds. The technology was developed in collaboration with the U.S. military to address complex battlefield injuries and is now used in clinical settings for diabetic ulcers and surgical sites. OxyBand's platform eliminates the need for bulky hyperbaric chambers, offering a portable and cost-effective solution for oxygen therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OxyBand Technologies.